Marvell Technology, Inc. (MRVL) will report second-quarter fiscal 2025 results on Aug. 29 after market close.Marvell projects total revenues for the fiscal second quarter of $1.25 billion (+/- 5%). The Zacks Consensus Estimate for revenues is pegged at $1.25 billion, which indicates a decrease of 6.7% from the year-ago quarter’s reported figure.MRVL anticipates non-GAAP earnings per share (EPS) of 29 cents (+/- 5 cents) for the second quarter. The consensus mark for non-GAAP EPS has remained unchanged at 29 ...

A solid set of results could give this chip stock a nice boost.Shares of Marvell Technology (MRVL 1.29%) are up 14% year to date, and there is a good chance the stock could get a nice shot in the arm when it releases its fiscal 2025 second-quarter results on Aug. 29.Though Marvell may be trailing the 22% gain clocked by the PHLX Semiconductor Sector index, the company's growing revenue from sales of artificial intelligence (AI) chips is driving outstanding results for its data-center segment.Marvell is faci ...

Wall Street analysts forecast that Marvell Technology (MRVL) will report quarterly earnings of $0.29 per share in its upcoming release, pointing to a year-over-year decline of 12.1%. It is anticipated that revenues will amount to $1.25 billion, exhibiting a decline of 6.7% compared to the year-ago quarter.Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course ...

JHVEPhoto This “all AI, all the time” world for chip companies has certainly been a boon for Marvell Technology, Inc. (NASDAQ:MRVL), not only as demand for electro-optics (used for high-speed interconnect) and ramping custom silicon has helped mitigate major cyclical declines in other parts of the business, but as investors have piled into the hot theme of the day. Marvell shares are up about 60% since my last update, lagging names like Broadcom Inc. (AVGO) and NVIDIA Corporation (NVDA) as well as the b ...

JHVEPhoto Valuations across the Information Technology sector have been volatile in the last handful of months. Its P/E multiple climbed above 30 earlier this year before pulling back to near 28 at the April market trough. The same pattern played out from the July peak to the August nadir. Today, I.T. trades at 29.4 times forward earnings estimates, about five turns above its 5-year average. Much of the valuation premium stems from optimism around the AI trade. Near record-high margins today support a l ...

Marvell Technology, Inc.’s (MRVL) shares have rallied more than 14% over the past week. This exceeds the broader market's performance, with the S&P 500 and the Zacks Computer and Technology sector rising 3.5% and 4.9%, respectively.The impressive rise in Marvell’s shares is part of a broader recovery in the market following a sell-off in early August 2024. The market correction was primarily driven by fears of a potential U.S. recession, spurred by concerns over the Federal Reserve's interest rate policies ...

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Marvell Technology (MRVL) .Marvell currently has an average brokerage recommendation (ABR) of 1 ...

Marvel Announces Its Collaboration with FRAXA to Test MB204 In Pre-Clinical Models of Fragile X SyndromeAugust 13, 2024 9:00 AM EDT | Source: Marvel Biosciences Corp.Calgary, Alberta--(Newsfile Corp. - August 13, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased to announce it has entered a collaboration with the FRAXA Research Foundation to test its lead asset MB204 in a ...

Awarded Most Innovative Sustainability Technology for Marvell® Structera™ X CXL Memory-Expansion Controller SANTA CLARA, Calif., Aug. 7, 2024 /PRNewswire/ -- Marvell Technology, Inc. (NASDAQ: MRVL), a leader in data infrastructure semiconductor solutions, today announced it will showcase its industry-leading cloud storage and CXL memory technologies for AI, ML and other data-intensive workloads at the Flash Memory Summit, taking place August 6–8, 2024 at the Santa Clara Convention Center. Marvell was honore ...

文章核心观点 公司推出了Structera CXL产品线,包括Structera A和Structera X两个系列,旨在帮助云数据中心运营商解决内存性能和扩展方面的挑战[2]。 关于Structera A系列 1) Structera A系列是一种新型的CXL近内存加速器,集成了服务器级处理器内核和多个内存通道,可以提高深度学习等高带宽内存应用的性能[4][6] 2) Structera A 2504加速器支持高达200GB/s的内存带宽和4TB的内存容量[6] 3) 将Structera A加速器添加到单个64核处理器服务器中,可以将计算核心数增加25%、内存带宽增加50%、内存容量增加4TB、每核内存带宽增加25%,并提高内存带宽能效[7] 关于Structera X系列 1) Structera X系列是CXL内存扩展控制器,可以为通用服务器添加TB级内存容量,适用于内存数据库等高内存容量应用[8] 2) Structera X 2404是业界首款支持4通道DDR4内存和3DPC(每通道3个DIMM)的CXL内存扩展产品,可以让运营商重复利用退役服务器的DDR4内存模块[9][10] 3) 重复利用DDR4内存可以大幅降低每台服务器的资本支出[10] 其他亮点 1) Structera产品线是业界首款集成Arm Neoverse V2处理器、内联压缩和4通道内存的产品[1][4] 2) Structera产品线支持硬件内联压缩和加密功能[11][20][21][22] 3) 公司正在与业界合作伙伴密切合作,推动CXL技术在数据中心的广泛应用[14][15][16][17][18]